"Community pharmacists have an opportunity to engage with patients who might be at risk of opioid use disorder or of overdose," said Assist. Prof. Laura Palombi.
David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.
The long-term goal is to develop a pharmacist workforce that can effectively cross over between mental health and primary care.
Several of our faculty are tackling the opioid addiction alongside and in partnership with the surrounding communities.
CoP survey found many MN jails don’t have the infrastructure or planning in place to support inmates with mental illnesses, particularly upon release.
1st year student Jacob Schally says, “I’ve met some incredible pharmacists and I want to work hard so I can follow in their footsteps.”